NeuroSense Therapeutics (NRSN) Common Equity (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Common Equity came in at -$1.6 million in Q4 2025, down 160.39% year-over-year from $2.6 million in Q4 2024, and down 200.58% quarter-over-quarter from -$519000.0 in Q2 2025.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Common Equity (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Common Equity across 6 years of filings, most recently posting -$1.6 million for Q4 2025.
- In Q4 2025, Common Equity fell 160.39% year-over-year to -$1.6 million; the TTM figure through Dec 2025 stood at -$1.6 million (down 160.39% YoY), while the FY2025 annual figure was -$1.6 million, down 160.39% from the prior year.
- Common Equity came in at -$1.6 million for Q4 2025 at NeuroSense Therapeutics, down from -$519000.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $12.1 million in Q1 2022 to a low of -$7.0 million in Q1 2024.
- Average Common Equity over 5 years is $2.5 million, with a median of $1.3 million recorded in 2023.
- Year-over-year, Common Equity surged 1544.01% in 2021 and plunged 1337.76% in 2024.
- Over 5 years, Common Equity stood at $10.8 million in 2021, then slumped by 46.06% to $5.8 million in 2022, then plunged by 130.1% to -$1.8 million in 2023, then jumped by 246.84% to $2.6 million in 2024, then plunged by 160.39% to -$1.6 million in 2025.
- Per Business Quant data, the three most recent Common Equity figures were -$1.6 million in Q4 2025, -$519000.0 in Q2 2025, and $2.6 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 11.69 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 11.83 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 20.25 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 31.71 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 6.76 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 8.42 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 18.85 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 4.92 Bn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | -1.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.56 Mn |
| Jun 30, 2025 | -519,000.00 |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | -2.82 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | -6.99 Mn |
| Dec 31, 2023 | -1.76 Mn |
| Sep 30, 2023 | -196,000.00 |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 2.89 Mn |
| Dec 31, 2022 | 5.84 Mn |
| Sep 30, 2022 | 7.85 Mn |
| Jun 30, 2022 | 9.84 Mn |
| Mar 31, 2022 | 12.11 Mn |
| Dec 31, 2021 | 10.83 Mn |
| Dec 31, 2020 | 659,000.00 |
API Access
NeuroSense Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();